OBJECTIVE: Allergen immunotherapy has been practiced to the general satisfaction of allergist and patients. In many studies, suppression of seasonal increase in specific IgE, late decline in specific IgE, increase in specific IgG1, IgG4 during immunotherapy have been noted. In our allergic rhinitis clinics, we encountered patients who complained of no improvement of allergic nasal symptoms in the early period of immunotherapy and stopped the treatment. There have been many studies showing the changes of levels of serum specific immunoglobulins to allergen at the finish of immunotherapy, but not in early period of immunotherapy. METHOD: We enrolled 50 allergic rhinitis (AR) patients who sensitized to Dermatophagoides farinae (Dfa) through allergic skin test (AST) or MAST, and treated by immunotherapy. We measured the levels of Dfa-specific IgE, IgA, IgG1, and IgG4 in serum by ELISA, and compared those between before and after 6 months of immunotherapy. During the course of the study allergic symptoms were measured by nasal symptom score that composed of 4 questionnaires including nasal obstruction, rhinorrhea, sneezing, and nasal pruritis. RESULTS: Nasal symptom score after 6 months of immunotherapy in AR patients were significantly lower than those before immunotherapy. Dfa-specific IgA levels after 6 months of immunotherapy in AR patients were significantly higher than those before immunotherapy. In contrast, Dfa-specific IgE and IgG4 levels after 6 months of immunotherapy in AR patients were significantly lower than those before immunotherapy. Dfa-specific IgG1 levels after 6 months of immunotherapy in AR patients were insignificantly lower than those before immunotherapy. The changes of Dfa-specific IgE levels were significantly correlated with those of nasal symptom scores after 6 months of immunotherapy in AR patients. But the changes of Dfa-specific IgA,IgG1,IgG4 levels were insignificantly correlated with those of nasal symptom scores after 6 months of immunotherapy in AR patients. CONCLUSION: We found that the changes of levels of serum specific immunoglobulins to allergen, and those of symptom scores may occur even at the early period of immunotherapy in AR patients. We also found that the decrease of serum specific IgE to allergen may contribute to the improvement of allergic symptoms in the early period of immunotherapy. Further studies will be needed to compare the changes of levels of serum specific immunoglobulins to allergen and symptom scores between early and late periods after immunotherapy in AR patients.
OBJECTIVE:
Chitin is a recognition element for tissue infiltration by innate cells implicated in allergy and immunity. This process can be negatively regulated by vertebrate chitinases. Both acidic mammalian chitinase (AMCase) and chitotriosi-dase (ChT) have chitinolytic activity. The present study aimed to determine the activities of AMCase and ChT in nasal polyps (NPs), as well as their in situ localization and expression in NP tissue. METHOD: AMCase and ChT activities in NPs were compared with those in inferior turbinate tissue samples. Tissue samples were measured for AMCase and ChT activities at a range of pHs using the fluorogenic substrate 4-methylumbelliferyl-␤-D-N,N/,N//-triacetyl-chitotriose. Immunofluorescent staining for the localization of both AMCase and ChT was performed using NP cryosections. RESULTS: Both AMCase and ChT displayed markedly increased chitinolytic activity in all NPs, compared with inferior turbinate tissues. Both AMCase and ChT displayed a cytoplasmic distribution in CD 68ϩ histiocytes of the submucosa and CD68Յ interstitial stromal cells. CONCLUSION: The increased chitinolytic activities of AM-Case and ChT in NPs may be important in NP pathogenesis, suggesting that inhibition of chitinolytic activity may be a novel therapeutic strategy for the treatment of NPs.
Cold Dry Air Provocation for Detecting Nasal Hyperreactivity
Young Hyo Kim, MD, MPH (presenter); Tae Young Jang, MD, PhD OBJECTIVE: Cold dry air is one of the methods to evaluate nonspecific hyperreactivity. However, there is no research about nasal volume and dimension after cold dry air provocation. In this aspect, acoustic rhinometry is one of the useful tool in assessing nasal cavity volume and dimension more objectively. The authors aimed to detect nonspecific hyperreactivity using cold dry air provocation with acoustic rhinometry. METHOD: Twenty-one healthy volunteers, 24 allergic patients, and 32 nonallergic patients were enrolled. Cold dry air provocation with acoustic rhinometry was performed on all patients. The change of symptoms using VAS (Visual Analogue Scale), amount of rhinorrhea, and change of total nasal volume and minimal cross-sectional area were checked in all three groups. RESULTS: Patient group showed greater change of nasal symptoms, more rhinorrhea and greater change of total nasal volume (TNV) and Minimal Cross-sectional Area (MCA). Patient group with history of nonspecific hyperreactivity showed more change than those without it. CONCLUSION: Cold dry air provocation with acoustic rhinometry could be a useful adjunctive tool in detecting nonspecific hyperreactivity. 
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